Bank of Nova Scotia’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-98,000
Closed -$9.95M 1127
2025
Q4
$9.95M Buy
+98,000
New +$7.87M 0.01% 481
2025
Q3
Sell
-4,577
Closed -$243K 1081
2025
Q2
$243K Sell
4,577
-11,600
-72% -$589K ﹤0.01% 941
2025
Q1
$700K Buy
16,177
+183
+1% +$9.27K ﹤0.01% 779
2024
Q4
$899K Buy
15,994
+4,761
+42% +$296K ﹤0.01% 795
2024
Q3
$765K Buy
+11,233
New +$634K ﹤0.01% 794
2024
Q2
Sell
-2,966
Closed -$205K 1022
2024
Q1
$205K Buy
2,966
+108
+4% +$6.83K ﹤0.01% 964
2023
Q4
$211K Buy
+2,858
New +$187K ﹤0.01% 967
2023
Q1
Sell
-5,353
Closed -$265K 1164
2022
Q4
$265K Buy
+5,353
New +$219K ﹤0.01% 1058
2022
Q2
Sell
-3,707
Closed -$259K 1199
2022
Q1
$259K Buy
+3,707
New +$271K ﹤0.01% 1124
2021
Q4
Sell
-4,725
Closed -$451K 1226
2021
Q3
$451K Buy
4,725
+202
+4% +$21.3K ﹤0.01% 1034
2021
Q2
$562K Buy
+4,523
New +$540K ﹤0.01% 943
2017
Q3
Sell
-41,900
Closed -$1.48M 951
2017
Q2
$1.48M Buy
+41,900
New +$1.29M 0.01% 688

Other funds holding EXAS

Bank of Nova Scotia's EXAS Position: Q1 2026 in Review

Bank of Nova Scotia sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 98,000 shares — an estimated $9.95M sold.

Bank of Nova Scotia first reported a position in EXAS in Q2 2017 and held it in 12 quarters. The position peaked at $9.95M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bank of Nova Scotia reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank of Nova Scotia sold 98,000 Exact Sciences shares in Q1 2026, an estimated $9.95M.
  • Bank of Nova Scotia first reported a position in Exact Sciences in Q2 2017 and held it in 12 quarters.
  • Bank of Nova Scotia's Exact Sciences position peaked at $9.95M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.